Next-Generation Engineering for Enhanced Myeloid Cell Therapies
Time: 2:00 pm
day: Conference Day Two
Details:
- Enhancing function in monocytes and macrophages with novel CAR architectures
- Utilizing HSCs as a cell source for ex vivo monocyte cell therapies
